表紙
市場調查報告書

歐洲的機械性血栓消除市場

Europe Market for Mechanical Thrombectomy 2017 - MedCore

出版商 iData Research Inc. 商品編碼 482460
出版日期 內容資訊 英文 268 Pages
商品交期: 最快1-2個工作天內
價格
歐洲的機械性血栓消除市場 Europe Market for Mechanical Thrombectomy 2017 - MedCore
出版日期: 2016年12月01日內容資訊: 英文 268 Pages
簡介

本報告提供機械性血栓消除的歐洲市場相關調查分析,提供市場規模和市場趨勢(銷售數·平均價格·市場價值·成長趨勢),主要市場促進·阻礙因素,市場佔有率驗證,再彙整相關疾病和臨床實驗趨勢等市場背景情況等相關資訊,為您概述為以下內容。

圖表一覽

摘要整理

歐洲的神經調節·神經血管·腦神經外科·監測設備市場:概要

競爭分析

市場趨勢

市場發展

調查對象市場

調查對象治療

主要調查更新

過去的版本

第1章 調查手法

  • 調查範圍
  • IDATA的9等級的調查方法

第2章 疾病概要

  • 基本結構
  • 病情·障礙
    • 簡介
    • 整體性診斷·神經外科
    • 腦瘍·腦瘤
    • 腦動靜脈畸形
    • 缺血性中風
    • 腦動脈瘤
    • 腦脊髓液·顱內壓相關的疾病
      • 水腦症·腦壓亢進症
      • 腦水腫
    • 神經調節的適應症
    • 創傷性腦損傷

第3章 各國簡介

  • 簡介
    • 人口
    • 平均每位國民的GDP
    • 物價指數
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 荷比盧三國
  • 斯堪地那維亞各國
  • 奧地利
  • 瑞士
  • 葡萄牙

第4章 產品評估

  • 產品系列
    • 機械性血栓消除
  • 法規上的問題和回收
  • 臨床實驗

第5章 機械性血栓消除市場

  • 簡介
  • 市場概要
  • 市場分析與預測
    • 血栓回收設備
    • 血栓消除導管市場
  • 市場推動成長·阻礙因素
    • 推動因素
    • 阻礙因素
  • 市場佔有率分析

簡稱一覽

附錄:企業的新聞稿

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_EUNEUR17_MC_MT

Ischemic Stroke is caused by an obstruction within a blood vessel that is supplying blood to the brain. This is often caused by blood clots but can also be caused by other substances like plaques. The gold standard treatment for strokes for many years has been the administration of clot dissolving or clot busting medication called tissue plasminogen activator (tPA). This type of drug must be administered as soon as possible, with a four hour window from symptom onset, to increase chances of recovery. A significant number of patients do not get to healthcare facilities quickly enough to meet that window and even some of those who do, later experience hemorrhagic complications from the medication. It is very effective for smaller clots but often fails to break up larger clots. Some patients cannot receive tPA, in which cases physicians rely on antiplatelet or anticoagulant medicine to ensure blood clots do not get larger.

General Report Contents:

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions

There will be significant market growth in the mechanical thrombectomy market over the forecast period, driven by growth in unit sales as mechanical thrombectomy is adopted as standard of care for acute ischemic stroke patients.

This market includes stent retrievers and suction thrombectomy catheters. The majority of the time a combination of the two categories is used but there a number of factors that can impact treatment decisions, one key factor being physician preference. Studies found new stent retriever devices are superior to first generation aspiration devices but there have been fewer studies comparing the second generation of both categories. There had been a strong evolution in Europe towards combination of aspiration and stent retriever but now the market is moving even farther towards aspiration only techniques. Both categories of devices have are required in specific cases as certain devices appear to more successful based on the anatomy, clot morphology and clot locations. There has been huge variability on reported success rates with aspiration-only which influences the frequency that a stent retriever is required in combination. Additional clinical trials will influence whether the devices continue to be used in conjunction or whether one category will cannibalize shares form the other.

The ASP of both categories of devices is expected to remain stable over the forecast period. The stent retriever drives the market value higher quicker due to the higher ASP it commands and the need for more than one device per procedure.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPEAN NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

MARKETS INCLUDED

PROCEDURES INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1. RESEARCH SCOPE
  • 1.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. BASIC ANATOMY
  • 2.2. DISEASE PATHOLOGY AND DISORDERS
    • 2.2.1. Introduction
    • 2.2.2. General Diagnostics and Neurosurgery
    • 2.2.3. Tumor and Brain Cancer
    • 2.2.4. Brain Arteriovenous Malformations
    • 2.2.5. Ischemic Stroke
    • 2.2.6. Brain Aneurysm
    • 2.2.7. Disorders Related to Cerebrospinal Fluids and Intracranial Pressure
      • 2.2.7.1. Hydrocephalus and Intracranial Pressure Disorder
      • 2.2.7.2. Cerebral Edema
    • 2.2.8. Indication for Neuromodulation
    • 2.2.9. Traumatic brain injury

COUNTRY PROFILES

  • 3.1. INTRODUCTION
    • 3.1.1. Population
    • 3.1.2. GDP Per Capita
    • 3.1.3. Price Index
  • 3.2. GERMANY
  • 3.3. FRANCE
  • 3.4. UNITED KINGDOM
  • 3.5. ITALY
  • 3.6. SPAIN
  • 3.7. BENELUX
  • 3.8. SCANDINAVIA
  • 3.9. AUSTRIA
  • 3.10. SWITZERLAND
  • 3.11. PORTUGAL

PRODUCT ASSESSMENT

  • 4.1. PRODUCT PORTFOLIOS
    • 4.1.1. Mechanical Thrombectomy
      • 4.1.1.1. Introduction
      • 4.1.1.2. Product Matrix for Mechanical Trombectomy device: Core Companies
  • 4.2. REGULATORY ISSUES AND RECALLS
    • 4.2.1. Mechanical Thrombectomy
  • 4.3. CLINICAL TRIALS
    • 4.3.1. Mechanical Thrombectomy

MECHANICAL THROMBECTOMY MARKET

  • 5.1. INTRODUCTION
  • 5.2. MARKET OVERVIEW
  • 5.3. MARKET ANALYSIS AND FORECAST
    • 5.3.1. Stent Retriever Market
    • 5.3.2. Thrombectomy Catheter Market
  • 5.4. DRIVERS AND LIMITERS
    • 5.4.1. Market Drivers
    • 5.4.2. Market Limiters
  • 5.5. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

APPENDIX: COMPANY PRESS RELEASES

LIST OF CHARTS

  • Chart 1-1: Neurological Device Market by Segment, Europe, 2013 - 2023
  • Chart 1-2: Neurological Device Market Overview, Europe, 2013 &2023
  • Chart 3-1: Country Profile, Germany, 2016
  • Chart 3-2: Country Profile, France, 2016
  • Chart 3-3: Country Profile, United Kingdom, 2016
  • Chart 3-4: Country Profile, Italy, 2016
  • Chart 3-5: Country Profile, Spain, 2016
  • Chart 3-6: Country Profile, Benelux, 2016
  • Chart 3-7: Country Profile, Scandinavia, 2016
  • Chart 3-8: Country Profile, Austria, 2016
  • Chart 3-9: Country Profile, Switzerland, 2016
  • Chart 3-10: Country Profile, Portugal, 2016
  • Chart 5-1: Mechanical Thrombectomy Market by Segment, U.S., 2013 - 2023
  • Chart 5-2: Mechanical Thrombectomy Market Breakdown, U.S., 2016
  • Chart 5-3: Mechanical Thrombectomy Market Breakdown, U.S., 2023
  • Chart 5-4: Stent Retriever Market, Europe, 2013 - 2023
  • Chart 5-5: Thrombectomy Catheter Market, Europe, 2013 - 2023
  • Chart 5-6: Leading Competitors, Mechanical Thrombectomy Market, U.S., 2016

LIST OF FIGURES

  • Figure 1-1: Neurological Device Market Share Ranking by Segment, Europe, 2016 (1 of 3)
  • Figure 1-2: Neurological Device Market Share Ranking by Segment, Europe, 2016 (2 of 3)
  • Figure 1-3: Neurological Device Market Share Ranking by Segment, Europe, 2016 (3 of 3)
  • Figure 1-4: Companies Researched in this Report, Europe, 2016
  • Figure 1-5: Factors Impacting the Neurological Device Market by Segment, Europe (1 of 3)
  • Figure 1-6: Factors Impacting the Neurological Device Market by Segment, Europe (2 of 3)
  • Figure 1-7: Factors Impacting the Neurological Device Market by Segment, Europe (3 of 3)
  • Figure 1-8: Recent Events in the Neurological Device Market, Europe, 2014 - 2016
  • Figure 1-9: Neurological Device Markets Covered, Europe, 2016
  • Figure 1-10: Neurological Device Procedures Covered, Europe, 2016
  • Figure 1-11: Key Report Updates
  • Figure 1-12: Version History
  • Figure 2-1: Neurology Disease Overview
  • Figure 2-2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016
  • Figure 4-1: Class 2 Device Recall: Trevo Pro 4 Stent Retriever
  • Figure 4-2: Mechanical Trombectomy: Comparison of Thrombectomy and Standard Care for Ischemic Stroke
  • Figure 4-3: Mechanical Trombectomy: Interest of Direct Aspiration First Pass Technique (ADAPT)
  • Figure 4-4: Mechanical Trombectomy: Case Review of the Penumbra and Indigo Systems for Mechanical Thrombectomy
  • Figure 4-5: Mechanical Trombectomy: Evaluation of the ReVive SE Device for Intra-Arterial Thrombectomy in Acute Ischemic Stroke
  • Figure 4-6: Mechanical Trombectomy: Trial and Cost Effectiveness Evaluation of Intra-arterial Thrombectomy
  • Figure 5-1: Mechanical Thrombectomy Market by Segment, Europe, 2013 - 2023 (€M)
  • Figure 5-2: Mechanical Thrombectomy Market by Segment, Europe, 2013 - 2023 (US$M)
  • Figure 5-3: Stent Retriever Market, Europe, 2013 - 2023 (€ and US$)
  • Figure 5-4: Thrombectomy Catheter Market, Europe, 2013 - 2023 (€ and US$)
  • Figure 5-5: Drivers and Limiters, Mechanical Thrombectomy Market, U.S., 2016
  • Figure 5-6: Leading Competitors, Mechanical Thrombectomy Market, U.S., 2016
  • Figure 7-1: Press Release Summary